GLOBAL GENOMICS GROUP

global-genomics-group-logo

Global Genomics Group is a big-data driven life sciences company.

#People #Website #More

GLOBAL GENOMICS GROUP

Social Links:

Industry:
Big Data Biotechnology Health Care Health Diagnostics Medical

Founded:
2012-01-01

Address:
Midlothian, Virginia, United States

Country:
United States

Website Url:
http://www.g3therapeutics.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
SPF Microsoft Exchange Online Amazon Microsoft Azure DNS GoDaddy DNS AWS Global Accelerator Rackspace Email Hosting



Current Advisors List

mark-goldstone_image

Mark Goldstone Board Member @ Global Genomics Group
Board_member
2013-01-01

Current Employees Featured

szilard-voros_image

Szilard Voros
Szilard Voros Founder and Chief Executive Officer @ Global Genomics Group
Founder and Chief Executive Officer

Founder


brad-brown_image

Brad Brown

idean-marvasty_image

Idean Marvasty

szilard-voros_image

Szilard Voros

Official Site Inspections

http://www.g3therapeutics.com

  • Host name: 164.239.12.198.host.secureserver.net
  • IP address: 198.12.239.164
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Global Genomics Group"

Drug Discovery Anchored in Human Target Validation

We identify and validate potential drug targets. We have sequenced every gene of the human genome in thousands of individuals, and measured hundreds of thousands of intermediate biomarkers, and can now identify and validate all …See details»

About Us | Novel Therapies for Serious Diseases | G3

What we do. We rejuvenate drug discovery by combining highly quantitative, deep phenotyping data from humans with a comprehensive, panomic molecular profiling approach, using unbiased, hypothesis-free bioinformatics and AI tools …See details»

G3 Therapeutics - LinkedIn

G3 Therapeutics (Global Genomics Group) is a data driven life sciences company leveraging molecular profiles of human health to develop life changing diagnostics and therapeutics. We are shifting ...See details»

G3 Therapeutics 2025 Company Profile: Valuation, Funding

Information on valuation, funding, acquisitions, investors, and executives for G3 Therapeutics. Use the PitchBook Platform to explore the full profile.See details»

G3T - Products, Competitors, Financials, Employees, Headquarters …

G3therapeutics.com. Overview & Products; People; Founded Year 2012. About G3T. G3T is involved in drug discovery and development within the biotechnology sector, focusing on …See details»

G3T Company Profile - Office Locations, Competitors, Revenue

G3T has 1 employees at their 1 location. See insights on G3T including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Global Genomics Group - Crunchbase Company Profile …

Global Genomics Group is a big-data driven life sciences company.See details»

Our Story - Read More | HOME

Soon after leaving the hospital, we started G3 Therapeutics (www.g3therapeutics.com) in 2012 after spending 15 years in academic medicine and preventive cardiology.The vision of G3 …See details»

G3t - Overview, News & Similar companies | ZoomInfo.com

Jan 12, 2023 View G3t (www.g3therapeutics.com) location in Virginia, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»

G3 Therapeutics (USA) Funding - medicalstartups.org

G3 Therapeutics is an innovative biopharmaceutical company, trailblazing the use of deep, panomic biological big data for drug discovery and development anchored in human genetic target...See details»

Aitia and G3 Therapeutics Publish Results Identifying New Causal ...

Jan 12, 2023 For additional information, please visit www.g3therapeutics.com About Aitia Aitia is the leader in the application of Causal AI and Digital Twins to discover the next generation of …See details»

Our Platform | Deep Drug Discovery, Genomic Data - G3 …

G3T is Rejuvenating Drug Development The current drug development process is no longer sustainable It is too risky, too long and too expensive. Currently, hypothesis-driven …See details»

Little (a), Big Risk: G3 Therapeutics Sets Out to Unravel Lp(a) …

Jan 4, 2024 G3 is trailblazing the next frontier of cardiovascular disease. SAN FRANCISCO, Jan. 4, 2024 /PRNewswire/ -- G3 Therapeutics ("G3"), a global leader in the use of multiomic …See details»

Get in Touch | Drug Target Validation Partner | G3 Therapeutics

Contact Brad Brown. Email: [email protected] 14701 Village Square, Place B Midlothian VA 23112 USASee details»

Partners & Investors | Pharmaceutical, Biotechnology | G3 …

Partner with us. G3T is developing assets in cardio-metabolic, metabolic and cardiovascular diseases, such as non-alcoholic steatohepatitis (NASH), obesity, diabetes, atherosclerosis, etc.See details»

News| Drug Discovery & Genomics Articles, Events | G3 Therapeutics

Read the latest news from G3 Therapeutics, pre-clinical biotechnology company using human biology data to develop novel therapeutic approaches to diseaseSee details»

G3 Pharmaceuticals - VentureRadar

"G3 pharmaceuticals is a development-stage biopharmaceutical company. We form partnerships with those scientists and clinicians around the world who have advanced the understanding of …See details»

G3therapeutics

G3therapeutics. 307 likes · 1 talking about this. Translating Deep Human Biology into Revelationary New TherapiesSee details»

Aitia and G3 Therapeutics Publish Results Identifying New Causal ...

Jan 13, 2023 For additional information, please visit www.g3therapeutics.com. About Aitia Aitia is the leader in the application of Causal AI and Digital Twins to discover the next generation …See details»

What to know about C3G treatments, from lifestyle adjustments to ...

2 days ago Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services …See details»